Codexis, Inc. (CDXS): who owns it and who trades it
As of Nov 16, 2026, CDXS insiders reported 14 open-market sales worth $931K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Opaleye Management Inc. (10% owner), with $878K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Codexis
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CDXS
148 funds and institutions reported CDXS shares worth $158M at the end of Q2 2026, about 77% of the company. The largest holder is BlackRock, Inc. with 8.0%.
Funds and institutions (13F) 77%Everyone else 23%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 7.28M | 8.02% | $16.5M | +4% |
| Nantahala Capital Management, LLC | 7.25M | 7.98% | $16.4M | +76% |
| Opaleye Management Inc. | 6.79M | 7.47% | $15.3M | No change |
| Aberdeen Group plc | 6.77M | 7.45% | $15.3M | -22% |
| Millennium Management LLC | 5.55M | 6.11% | $12.5M | +39% |
| Telemark Asset Management, LLC | 3.85M | 4.23% | $8.7M | No change |
| Ameriprise Financial Inc | 3.81M | 4.19% | $8.6M | +12% |
| Vanguard Capital Management LLC | 3.62M | 3.98% | $8.2M | -1% |
| Assenagon Asset Management S.A. | 2.56M | 2.81% | $5.8M | +240% |
| Geode Capital Management, LLC | 2.16M | 2.38% | $4.9M | +15% |
| State Street Corp | 1.76M | 1.93% | $4M | +5% |
| D. E. Shaw & Co., Inc. | 1.34M | 1.48% | $3M | +37% |
| Jacobs Levy Equity Management, Inc | 1.33M | 1.46% | $3M | +22% |
| Vanguard Portfolio Management LLC | 1.31M | 1.44% | $3M | +49% |
| AQR Capital Management LLC | 845,431 | 0.93% | $1.9M | +39% |
| Two Sigma Investments, LP | 696,599 | 0.77% | $1.6M | +188% |
| Northern Trust Corp | 682,940 | 0.75% | $1.5M | +4% |
| Franklin Resources Inc | 678,640 | 0.75% | $1.5M | -1% |
| Morgan Stanley | 649,170 | 0.71% | $1.5M | +37% |
| Vanguard Fiduciary Trust Co | 581,058 | 0.64% | $1.3M | +5% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CDXS insiders reported $0 of open-market purchases and $931K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Vre Raymond De | Director | Sale | 1,088 | $1.11 | $1.2K | Form 4 |
| Oct 12, 2026 | Alison Moore | CEO | Sale | 6,335 | $1.36 | $8.6K | Form 4 |
| Jun 11, 2026 | Vre Raymond De | Director | Sale | 2,605 | $2.37 | $6.2K | Form 4 |
| Feb 24, 2026 | Stefan Lutz | Chief Scientific Officer | Sale | 5,862 | $1.13 | $6.6K | Form 4 |
| Feb 6, 2026 | Stefan Lutz | Chief Scientific Officer | Sale | 2,492 | $1.31 | $3.3K | Form 4 |
| Feb 6, 2026 | Georgia Erbez | See Remarks | Sale | 3,826 | $1.31 | $5K | Form 4 |
| Jan 7, 2026 | Stefan Lutz | CSO | Sale | 4,685 | $1.70 | $8K | Form 4 |
| Dec 1, 2025 | Opaleye Management Inc. | 10% owner | Sale | 245,000 | $1.67 | $409K | Form 4 |
| Dec 1, 2025 | Opaleye Management Inc. | 10% owner | Sale | 8,533 | $1.67 | $14.3K | Form 4 |
| Nov 28, 2025 | Opaleye Management Inc. | 10% owner | Sale | 2,490 | $1.75 | $4.4K | Form 4 |
| Nov 28, 2025 | Opaleye Management Inc. | 10% owner | Sale | 105,000 | $1.75 | $184K | Form 4 |
| Nov 26, 2025 | Opaleye Management Inc. | 10% owner | Sale | 5,000 | $1.74 | $8.7K | Form 4 |
| Nov 26, 2025 | Opaleye Management Inc. | 10% owner | Sale | 148,318 | $1.74 | $258K | Form 4 |
| Nov 21, 2025 | Dennis P Wolf | Director | Sale | 8,952 | $1.56 | $14K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Opaleye Management Inc. | 10% owner | – | $878K | Dec 1, 2025 |
| Stefan Lutz | CSO | – | $17.9K | Feb 24, 2026 |
| Dennis P Wolf | Director | – | $14K | Nov 21, 2025 |
| Alison Moore | President and CEO, Director | – | $8.6K | Oct 12, 2026 |
| Vre Raymond De | Director | – | $7.4K | Nov 9, 2026 |
| Georgia Erbez | See Remarks | – | $5K | Feb 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CDXS short interest
Low short interest. 4.0% of CDXS shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went up 19%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.40M CDXS shares were sold short, 4.0% of the shares outstanding, down 11.2% from the report before. At the average daily volume of 898,826 shares, buying them all back would take about 4.9 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.40M | 4.02% | -11% | 898,826 | 4.9 |
| Oct 15, 2026 | 4.95M | 4.52% | +2% | 785,044 | 6.3 |
| Sep 30, 2026 | 4.84M | 4.42% | +20% | 967,632 | 5.0 |
| Sep 15, 2026 | 4.03M | 3.68% | +5% | 700,657 | 5.7 |
| Aug 31, 2026 | 3.85M | 3.51% | +3% | 1.08M | 3.6 |
| Aug 14, 2026 | 3.72M | 3.40% | -5% | 1.12M | 3.3 |
| Jul 31, 2026 | 3.93M | 4.32% | +5% | 1.91M | 2.1 |
| Jul 15, 2026 | 3.75M | 4.13% | +16% | 748,897 | 5.0 |
| Jun 30, 2026 | 3.23M | 3.55% | -1% | 1.06M | 3.0 |
| Jun 15, 2026 | 3.26M | 3.58% | -16% | 748,970 | 4.3 |
| May 29, 2026 | 3.88M | 4.27% | +5% | 768,685 | 5.0 |
| May 15, 2026 | 3.70M | 4.07% | -21% | 1.24M | 3.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Codexis company events
Codexis filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 10, 2026.
- Nov 10, 2026AgreementCodexis, Inc., a Delaware corporation and its wholly owned subsidiary, Codexis Mayflower Holdings, LLC, a Delaware limited liability company (together with the Company, the “Borrowers”) entered into that certain Loan and Security Agreement with the lenders party thereto from time to time and… Filing
- Aug 11, 2026ResultsReleased financial results. Filing
- Jul 27, 2026AnnouncementCodexis, Inc. entered into an underwriting agreement with Piper Sandler & Co. and Cantor Fitzgerald & Co., as representatives of the several underwriters named therein, pursuant to which the Company agreed to issue and sell 16,666,667 shares of its common stock, par value $0.0001 per share, to the… Filing
- Jul 23, 2026AnnouncementThe information contained in Item 2.02 above is incorporated herein by reference. Filing
- Jun 22, 2026VoteReported shareholder vote results. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 14, 2026LeadershipDennis Wolf notified the Board of Directors of Codexis, Inc. of his decision to resign from the Board, effective immediately. Filing
- Mar 11, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Codexis financials
Famous investors that hold CDXS
5 of the 50 well-known investors we track reported holding CDXS in their latest 13F filing. The largest position is Israel Englander's, worth $6.6M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 4.77M | $6.6M | 0.0% | -14% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 451,630 | $628K | 0.0% | +136% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 357,925 | $498K | 0.0% | No change |
| Jim Simons · Renaissance Technologies | Q3 2026 | 130,935 | $182K | 0.0% | +216% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 65,969 | $91.7K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named CDXS in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Lawrence W. Lytton | 13G/A | 4.8% |
| Nov 16, 2026 | Lawrence W. Lytton | 13G/A | 4.8% |
| Nov 6, 2026 | Opaleye Management Inc. | 13G/A | 2.4% |
| Nov 6, 2026 | Opaleye Management Inc. | 13G/A | 2.4% |
| Oct 30, 2026 | Aberdeen Group plc | 13G/A | 9.9% |
| Oct 30, 2026 | Aberdeen Group plc | 13G/A | 9.9% |
Questions about Codexis, Inc. (CDXS) stock
Who owns the most CDXS stock?
The largest reported owner of Codexis, Inc. (CDXS) is BlackRock, Inc., with 8.0% of the company. In total, 148 funds and institutions reported holding CDXS at the end of Q2 2026, together about 77% of the shares. See the largest owners.
Are CDXS insiders buying or selling?
In the last 12 months, CDXS insiders reported no open-market purchases and 14 sales worth $931K. The latest trade was on Nov 9, 2026. See every trade.
What is the short interest in CDXS?
As of Oct 30, 2026, 4.40M CDXS shares were sold short, 4.0% of the shares outstanding, down 11.2% from the report before. At the average daily volume of 898,826 shares, buying them all back would take about 4.9 trading days (days to cover). See the history.
Which famous investors hold CDXS?
5 of the 50 well-known investors we track reported CDXS in their latest 13F filing, including Israel Englander, Ken Griffin, Paul Tudor Jones. The largest position is worth $6.6M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.